3 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has grown 3.2% per year over the past 2 years.
Net income has grown slower than revenue (-38.2% vs 3.2% per year).
Free cash flow has declined 49.2% per year over the past 2 years.
Financial health
Total debt ($2.0B) exceeds cash ($534M); net debt is $1.5B.
Shareholder returns
Dividends have been paid for 1 consecutive year, consuming 632.9% of earnings and 1260.5% of free cash flow.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
2025
$3.9B
$237M
32.2%
0.0%
16.8%
4.2%
$119M
$2.0B
$534M
2024
$3.8B
$594M
34.6%
0.0%
18.2%
11.9%
$546M
$0
$661M
2023
$3.6B
$621M
35.2%
0.0%
—
—
$461M
—
—
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Return on equity & assets (ROE / ROA)
ROEROA
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
ROE
ROA
FCF
Total debt
Cash
Jun '26
$1.1B
$119M
32.2%
0.0%
7.5%
2.0%
$124M
$2.0B
$750M
Mar '26
$991M
$85M
31.9%
0.0%
5.7%
1.5%
$124M
$2.0B
$642M
Dec '25
$987M
$41M
26.1%
0.0%
2.9%
0.7%
$78M
$2.0B
$534M
Sep '25
$969M
-$35M
32.0%
0.0%
-1.1%
-0.7%
—
—
$417M
Jun '25
$1.0B
$97M
35.0%
0.0%
—
—
$74M
—
—
Mar '25
$897M
$134M
35.7%
0.0%
—
—
$98M
—
—
Dec '24
$913M
$133M
33.4%
0.0%
4.1%
2.7%
$180M
$0
$661M
Sep '24
$907M
$152M
36.6%
0.0%
—
—
—
—
—
Valuation over time
How the market has priced SOLS against its own fundamentals since 2025-10 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-earnings ratio has risen from 12.0× (Oct '25) to 41.4× (Nov '26).
The price-to-sales ratio has risen from 1.9× (Oct '25) to 2.5× (Nov '26).
The dividend yield has fallen from 19.4% (Dec '25) to 15.3% (Nov '26).
Price / earnings (P/E)
P/E
Price / sales (P/S)
P/S
Dividend yield (%)
Dividend yield %
Frequently asked questions
Is SOLS growing its revenue and profit?
Over the past 2 years, Solstice Advanced Materials Inc.'s revenue has grown 3.2% per year, and net income declined 38.2% per year. These are computed facts, not advice.
How much debt does SOLS have?
As of FY2025, Solstice Advanced Materials Inc. reported $2.0B of total debt against $534M of cash.
What is SOLS's profit margin?
In FY2025, gross margin was 32.2%, operating margin —, and net margin 6.1%.
What is SOLS's P/E ratio?
Solstice Advanced Materials Inc.'s P/E (TTM) is 46.78 as of the 2026-11-03 close — market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year, the same figure as on the SOLS stock page. The valuation chart above sets each month-end's price against the latest annual net income instead, so its latest point (about 41.4× as of Nov '26) can differ. These are computed facts, not advice.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.